Bleeding Risk Comparing Targeted Low-Dose Heparin With Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Bleeding Risk Comparing Targeted Low-Dose Heparin With Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention

Published:2011-10 Issue:5 Volume:4 Page:463-473
ISSN:1941-7640
Container-title:Circulation: Cardiovascular Interventions
language:en
Short-container-title:Circ Cardiovasc Interv

Author:

Bangalore Sripal¹,Cohen David J.¹,Kleiman Neal S.¹,Regev-Beinart Tal¹,Rao Sunil V.¹,Pencina Michael J.¹,Mauri Laura¹

Affiliation:

1. From the Department of Medicine, Division of Cardiovascular Medicine, New York University School of Medicine, New York, NY (S.B.); Saint Luke's Mid America Heart Institute, Kansas City, MO (D.J.C.); The Methodist DeBakey Heart and Vascular Center, Houston, TX (N.K.); The Duke Clinical Research Institute, Durham, NC (S.V.R.); Harvard Clinical Research Institute, Boston, MA (S.B., T.R.-B., L.M., M.J.P.); and Brigham and Women's Hospital, Boston, MA (L.M.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes

2. Periprocedural Bleeding and 1-Year Outcome After Percutaneous Coronary Interventions

3. Impact of Bleeding Severity on Clinical Outcomes Among Patients With Acute Coronary Syndromes

4. Impact of Major Bleeding on 30-Day Mortality and Clinical Outcomes in Patients With Acute Coronary Syndromes

5. Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention: results from the REPLACE-2 trial;Cohen DJ;J Am Coll Cardiol,2004

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Historical Perspective on the Reversal of Anticoagulants;Seminars in Thrombosis and Hemostasis;2022-09-02

2. Routine fixed-dose heparin vs. ACT-guided heparin administration for elective PCI and its influence on patient in-hospital outcome: a retrospective study;Coronary Artery Disease;2021-03-01

3. The Use of Bivalirudin in Pediatric Cardiac Surgery and in the Interventional Cardiology Suite;Journal of Cardiothoracic and Vascular Anesthesia;2020-08

4. Association Between Maximal Activated Clotting Time and Major Bleeding Complications During Transradial and Transfemoral Percutaneous Coronary Intervention;JACC: Cardiovascular Interventions;2018-06

5. Does VALIDATE-SWEDEHEART invalidate the use of bivalirudin in myocardial infarction?;Journal of Thoracic Disease;2018-01